L-asparaginase kills lymphoma cells by apoptosis
- PMID: 8485807
- DOI: 10.1007/BF00685615
L-asparaginase kills lymphoma cells by apoptosis
Abstract
Microscopic examination of histological sections of lymph nodes from a canine case of malignant lymphoma at 4 h after treatment with L-asparaginase revealed massive destruction of neoplastic cells by what was consistent with apoptosis morphologically. Apoptosis as the mode of cell death after asparaginase treatment was confirmed in a mouse lymphoma cell line (LY-TH) by the characteristic fragmentation of DNA into oligonucleosome-sized pieces and by the morphological changes consistent with apoptosis following treatment in vitro. Applied to these cells, asparaginase was found to be most cytotoxic over the range of 1-10 IU/ml. Even after 4 h of asparaginase treatment at 100 IU/ml, protein synthesis was reduced by only one-half, yet DNA fragmentation reached 40%. Other agents that affect protein synthesis (cycloheximide and actinomycin D) caused apoptosis as well; however, agents (radiation, prednisolone, and VP-16) whose mechanisms are different from inhibition of protein synthesis also caused apoptosis. As such, it seems unlikely that protein depletion per se and/or the elimination of specific short-lived proteins is the triggering event that leads to cell death. It is more likely that the suspension of cellular proliferation commits cells to apoptosis after asparaginase treatment.
Similar articles
-
Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase.Leukemia. 1997 Nov;11(11):1858-61. doi: 10.1038/sj.leu.2400834. Leukemia. 1997. PMID: 9369418
-
Modulation of apoptosis and enhancement of chemosensitivity by decreasing cellular thiols in a mouse B-cell lymphoma cell line that overexpresses bcl-2.Cancer Chemother Pharmacol. 1999;44(5):362-6. doi: 10.1007/s002800050990. Cancer Chemother Pharmacol. 1999. PMID: 10501908
-
Growth inhibitory and proapoptotic effects of l-asparaginase from Fusarium culmorum ASP-87 on human leukemia cells (Jurkat).Fundam Clin Pharmacol. 2017 Jun;31(3):292-300. doi: 10.1111/fcp.12257. Epub 2016 Dec 30. Fundam Clin Pharmacol. 2017. PMID: 27885727
-
Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.Clin Pharmacokinet. 2005;44(4):367-93. doi: 10.2165/00003088-200544040-00003. Clin Pharmacokinet. 2005. PMID: 15828851 Review.
-
Recent developments in L-asparaginase discovery and its potential as anticancer agent.Crit Rev Oncol Hematol. 2016 Apr;100:1-10. doi: 10.1016/j.critrevonc.2015.01.002. Epub 2015 Jan 12. Crit Rev Oncol Hematol. 2016. PMID: 25630663 Review.
Cited by
-
Amino acid metabolism in hematologic malignancies and the era of targeted therapy.Blood. 2019 Sep 26;134(13):1014-1023. doi: 10.1182/blood.2019001034. Epub 2019 Aug 15. Blood. 2019. PMID: 31416801 Free PMC article. Review.
-
Association between serum arginine levels and cancer risk: A community-based nested case-control study.Front Nutr. 2022 Nov 17;9:1069113. doi: 10.3389/fnut.2022.1069113. eCollection 2022. Front Nutr. 2022. PMID: 36466394 Free PMC article.
-
The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers.Cancers (Basel). 2018 Sep 21;10(10):346. doi: 10.3390/cancers10100346. Cancers (Basel). 2018. PMID: 30248941 Free PMC article. Review.
-
E. coli-Derived L-Asparaginase Retains Enzymatic and Cytotoxic Activity In Vitro for Canine and Feline Lymphoma after Cold Storage.Vet Med Int. 2013;2013:786162. doi: 10.1155/2013/786162. Epub 2013 Apr 28. Vet Med Int. 2013. PMID: 23738234 Free PMC article.
-
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1272-7. doi: 10.1073/pnas.1014739108. Epub 2011 Jan 5. Proc Natl Acad Sci U S A. 2011. PMID: 21209329 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials